PortViewPortView
CANC logo

Tema Oncology (CANC) ETF Holdings & Analysis

ETFOther

$43.69+0.03%
1-year price historyRange $26.74 – $45.24
52-week range$43.69
$26.62$47.00

What CANC does

The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.

Fund profile

Category
Other
AUM
$138.60M
Holdings
10
52-week high
$47.00
52-week low
$26.62

Top holdings

Top 1039%
HoldingWeight
REVOLUTION MEDICINES INC5.38%
COGENT BIOSCIENCES INC4.91%
MERCK & CO INC4.59%
ELI LILLY & CO4.39%
NOVARTIS AG3.98%
BRISTOL-MYERS SQUIBB CO3.55%
ABBVIE INC3.34%
BEONE MEDICINES LTD3.15%
JOHNSON & JOHNSON3.13%
IMMUNOME INC2.94%

Sector allocation

Healthcare100.00%

Geographic allocation

United States80.71%
Switzerland10.05%
Denmark2.87%
United Kingdom3.04%
China1.92%
Germany0.80%
Other0.62%

PortView Portfolio Insights

PortView analyzes how CANC fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CANC in PortView →

Related securities

Related stocks

Frequently asked questions

What does CANC track?
CANC is the Tema Oncology ETF, a Other ETF.
What is the expense ratio of CANC?
Expense ratio data for CANC is shown on the page when available from our data provider.
What are the largest holdings in CANC?
Top holdings include RVMD, COGT, MRK, LLY, NOVN.SW.
How can PortView analyze CANC overlap with other ETFs?
PortView computes the holdings overlap between CANC and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.